Close

Ratings by TD Cowen (Yaron Werber)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/26/2024 Stoke Therapeutics STOK Upgrade Buy
(Hold)
6.50
(13.50)
107.69% Details
3/21/2024 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
3/18/2024 Jasper Therapeutics JSPR New Coverage Buy
(N/A)
25.08
(29.36)
17.07% Details
3/15/2024 Immuneering Corporation IMRX Downgrade Hold
(Buy)
5.88
(2.89)
-50.85% Details
1/31/2024 2Seventy Bio Inc. TSVT Downgrade Hold
(Buy)
3.49
(5.35)
53.3% Details
1/25/2024 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
1/10/2024 Ascendis Pharma ASND Maintain Hold
(N/A)
 
 
  Details
12/21/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
12/20/2023 Celldex Therapeutics CLDX New Coverage Buy
(N/A)
37.92
(41.97)
10.68% Details
12/19/2023 Ascendis Pharma ASND Maintain Hold
(N/A)
 
 
  Details
12/12/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
11/7/2023 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
10/19/2023 Generation Bio GBIO Downgrade Hold
(Buy)
3.11
(4.07)
30.87% Details
8/8/2023 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
7/28/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
7/25/2023 Stoke Therapeutics STOK Downgrade Hold
(Buy)
9.53
(13.50)
41.66% Details
7/17/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
6/26/2023 FibroGen FGEN Maintain Hold
(N/A)
 
 
  Details
5/8/2023 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
3/28/2023 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
2/28/2023 FibroGen FGEN Maintain Hold
(N/A)
 
 
  Details
2/27/2023 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
1/25/2023 Ascendis Pharma ASND Maintain Hold
(N/A)
 
 
  Details
1/25/2023 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
1/25/2023 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Ascendis Pharma ASND Maintain Hold
(N/A)
 
 
  Details
11/3/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
11/2/2022 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
11/1/2022 Legend Biotech Corp. LEGN New Coverage Buy
(N/A)
49.82
(56.09)
12.59% Details
11/1/2022 Instil Bio Inc TIL Downgrade Hold
(Buy)
5.25
(10.80)
105.71% Details
8/17/2022 BioNTech BNTX Maintain Hold
(N/A)
 
 
  Details
8/9/2022 FibroGen FGEN Maintain Hold
(N/A)
 
 
  Details
5/12/2022 Ascendis Pharma ASND Maintain Hold
(N/A)
 
 
  Details
5/10/2022 FibroGen FGEN Maintain Hold
(N/A)
 
 
  Details
5/2/2022 Genmab A/S GMAB New Coverage Hold
(N/A)
35.07
(29.91)
-14.71% Details
4/6/2022 bluebird bio BLUE Downgrade Hold
(Buy)
5.23
(1.28)
-75.53% Details
3/31/2022 Orchard Therapeutics ORTX Downgrade Hold
(Buy)
0.78
(16.70)
2041.03% Details
1/27/2022 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
1/27/2022 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
1/10/2022 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
1/6/2022 2Seventy Bio Inc. TSVT New Coverage Buy
(N/A)
22.89
(5.35)
-76.63% Details
1/6/2022 Ascendis Pharma ASND New Coverage Hold
(N/A)
123.37
(151.17)
22.53% Details
1/6/2022 2Seventy Bio TSTV New Coverage Buy
(N/A)
0.00
()
0% Details
11/30/2021 IO Biotech IOBT New Coverage Buy
(N/A)
8.74
(1.73)
-80.21% Details
11/5/2021 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
10/26/2021 Roivant Sciences ROIV New Coverage Buy
(N/A)
7.04
(10.54)
49.72% Details
10/1/2021 Acceleron Pharma XLRN Downgrade Hold
(Buy)
175.36
(178.75)
1.93% Details
9/27/2021 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
8/24/2021 Immuneering Corporation IMRX New Coverage Buy
(N/A)
29.43
(5.88)
-80.02% Details
8/6/2021 Dicerna Pharmaceuticals DRNA Downgrade Hold
(Buy)
37.92
(38.22)
0.79% Details
7/16/2021 FibroGen FGEN Maintain Hold
(N/A)
 
 
  Details
6/28/2021 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
6/23/2021 PMV Pharmaceuticals Inc. PMVP New Coverage Buy
(N/A)
31.03
(1.70)
-94.52% Details
4/13/2021 Instil Bio Inc TIL New Coverage Buy
(N/A)
21.94
(10.80)
-50.77% Details
3/8/2021 Nuvation Bio Inc NUVB New Coverage Buy
(N/A)
10.86
(3.64)
-66.48% Details
2/18/2021 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
2/18/2021 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
2/18/2021 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
2/3/2021 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
12/16/2020 Prevail Therapeutics PRVL Downgrade Hold
(Buy)
12.50
(23.00)
84% Details
12/15/2020 Ionis Pharmaceuticals IONS Upgrade Buy
(Hold)
47.83
(43.35)
-9.37% Details
12/14/2020 Olema Pharmaceuticals OLMA New Coverage Buy
(N/A)
43.28
(10.47)
-75.81% Details
11/17/2020 Foghorn Therapeutics FHTX New Coverage Buy
(N/A)
16.05
(6.71)
-58.19% Details
11/6/2020 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
10/29/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
10/28/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
10/22/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
8/10/2020 Relay Therapeutics RLAY New Coverage Buy
(N/A)
40.69
(8.30)
-79.6% Details
8/7/2020 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
8/6/2020 Regeneron Pharma REGN Maintain Hold
(N/A)
 
 
  Details
7/30/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
7/29/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
7/16/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
7/7/2020 Generation Bio GBIO New Coverage Buy
(N/A)
19.64
(4.07)
-79.28% Details
6/25/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
6/2/2020 Regeneron Pharma REGN Maintain Hold
(N/A)
 
 
  Details
5/26/2020 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
5/6/2020 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
5/1/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
5/1/2020 FibroGen FGEN New Coverage Hold
(N/A)
36.89
(2.35)
-93.63% Details
2/24/2020 Epizyme EPZM Maintain Buy
(N/A)
 
 
  Details
1/31/2020 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
1/28/2020 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
1/24/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
12/20/2019 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
12/19/2019 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
12/16/2019 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
12/16/2019 argenx SE ARGX Maintain Buy
(N/A)
 
 
  Details
11/13/2019 BeiGene, Ltd. BGNE Maintain Buy
(N/A)
 
 
  Details
11/5/2019 Regeneron Pharma REGN Maintain Hold
(N/A)
 
 
  Details
10/31/2019 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
10/30/2019 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
10/29/2019 Acceleron Pharma XLRN Maintain Buy
(N/A)
 
 
  Details
10/8/2019 Spring Works Therapeutics SWTX New Coverage Buy
(N/A)
18.67
(49.22)
163.63% Details
9/16/2019 argenx SE ARGX New Coverage Buy
(N/A)
124.89
(393.72)
215.25% Details
9/16/2019 Orchard Therapeutics ORTX New Coverage Buy
(N/A)
15.03
(16.70)
11.11% Details
8/26/2019 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
8/26/2019 Amgen AMGN Maintain Buy
(N/A)
 
 
  Details
7/15/2019 Stoke Therapeutics STOK New Coverage Buy
(N/A)
27.85
(13.50)
-51.53% Details
7/15/2019 Prevail Therapeutics PRVL New Coverage Buy
(N/A)
12.13
(23.00)
89.61% Details
6/14/2019 bluebird bio BLUE Maintain Buy
(N/A)
 
 
  Details
5/7/2019 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
5/2/2019 Exelixis EXEL Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Alector Inc. ALEC New Coverage Buy
(N/A)
19.59
(6.02)
-69.27% Details
2/26/2019 Zafgen ZFGN New Coverage Hold
(N/A)
4.84
(0.99)
-79.55% Details
2/26/2019 Rocket Pharmaceuticals RCKT New Coverage Buy
(N/A)
14.88
(26.94)
81.05% Details
2/26/2019 Unum Therapeutics UMRX New Coverage Hold
(N/A)
4.24
(2.35)
-44.58% Details
2/26/2019 Dicerna Pharmaceuticals DRNA New Coverage Buy
(N/A)
10.51
(38.22)
263.65% Details
2/26/2019 Exelixis EXEL New Coverage Buy
(N/A)
21.52
(23.73)
10.27% Details
2/26/2019 Amgen AMGN New Coverage Buy
(N/A)
187.50
(284.32)
51.64% Details
2/26/2019 BeiGene, Ltd. BGNE New Coverage Buy
(N/A)
137.78
(156.39)
13.51% Details
2/26/2019 Celgene CELG New Coverage Hold
(N/A)
89.14
(108.24)
21.43% Details
2/26/2019 bluebird bio BLUE New Coverage Buy
(N/A)
131.32
(1.28)
-99.03% Details
2/26/2019 Ultragenyx Pharma RARE New Coverage Buy
(N/A)
59.82
(46.69)
-21.95% Details
2/26/2019 Epizyme EPZM New Coverage Buy
(N/A)
11.85
(1.47)
-87.59% Details
2/26/2019 Acceleron Pharma XLRN New Coverage Buy
(N/A)
42.74
(178.75)
318.23% Details